Sunday 8 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB

Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.35 4.42 +1.81%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 105×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 4/9
ROIC: 1.94%
Net debt / EBITDA: 0.8×
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Biogen Inc. (BIIB) P/S ratio

Alert me on P/S ratio

As of 6 November 2026, Biogen Inc. (BIIB) trades at a P/S ratio of 3.6×. Over the past ten years it has ranged from 1.7× (April 2025) to 11.6× (March 2015); the current reading is higher than 45% of that period. That is in line with the Drug Manufacturers General industry median of 3.5× and in line with the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BIIB/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Biogen Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BIIB/metrics/ps-ratio">Biogen Inc. (BIIB) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	2.6×	13.28%
FY2024	2.3×	(41.57%)
FY2023	3.9×	1.15%
FY2022	3.9×	19.54%
FY2021	3.3×	11.16%
FY2020	2.9×	(24.11%)
FY2019	3.9×	(15.75%)
FY2018	4.6×	(20.82%)
FY2017	5.8×	11.09%
FY2016	5.2×	(20.64%)

Period	P/S ratio	Change
Sep 2026	3.2×	1.88%
Jun 2026	3.2×	17.19%
Mar 2026	2.7×	4.17%
Dec 2025	2.6×	27.78%
43 more quarters	Free account

Against its own ten years

Low 1.7× High 11.6×

Ten-year median 3.7×

Current reading's percentile 49

Company	P/S ratio
SNY Sanofi compare	1.9×
GSK GSK PLC Sponsored ADR compare	2.2×
BMY Bristol Myers Squibb Company compare	2.5×
PFE Pfizer Inc. compare	2.6×
NVO Novo Nordisk A/S compare	3.4×
BIIB Biogen Inc.	3.6×
AZN AstraZeneca PLC compare	4.6×
AMGN Amgen Inc. compare	6.4×
GILD Gilead Sciences, Inc. compare	6.7×
Drug Manufacturers General industry median	3.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

Biogen Inc. (BIIB) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BIIB

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on BIIB

Stockrow Weekly